Large gap with delayed quotes
|
Official
05/23/2026
-
02:04:00
|
Bid
05/22/2026 -
21:59:59
|
Bid Volume |
Ask
05/22/2026 -
21:59:59
|
Ask Volume |
|---|---|---|---|---|
|
86.39
+5.82
(
+7.22% )
|
86.37
|
1,000 |
86.74
|
600 |
Analysis date: 22.05.2026
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 19.05.2026.
Interest
Very strong
Very strong
Four stars since 19.05.2026.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 27.02.2026 at a price of 14.73.
Evaluation
Undervalued
Undervalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately undervalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 07.04.2026.
4wk Rel Perf
247.10%
247.10%
The four-week dividend-adjusted overperformance versus SP500 is 247.10%.
Sensibility
High
High
High, no change over 1 year.
Bear Market Factor
High
High
On average, the stock has a tendency to amplify the drops in the index by 1.59%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 9.29%.
Mkt Cap in $bn
1.44
1.44
With a market capitalization <$2bn, AGILON HEALTH is considered a small-cap stock.
G/PE Ratio
2.16
2.16
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 1.6 often suggests the projected growth is a result of a base effect, meaning the company can often be in a turn around situation. In this case, the estimated PE is a better indicator of a stock's expected growth than the Long Term Growth (LT Growth).
LT P/E
26.26
26.26
The estimated PE is for the year 2028.
LT Growth
56.60%
56.60%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
13
13
Over the last seven weeks, an average of 13 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
442
442
For 1% of index variation, the stock varies on average by 4.42%.
Correlation
0.28
0.28
Stock movements are strongly independent of index variations.
Value at Risk
77.91
77.91
The value at risk is estimated at USD 77.91. The risk is therefore 90.18%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
26.10.2021
26.10.2021